The rise of TIM-3: A promising immune target in diffuse midline gliomas

Iker Ausejo-Mauleon , Sara Nuin , Marta M. Alonso

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1536

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1536 DOI: 10.1002/ctm2.1536
EDITORIAL

The rise of TIM-3: A promising immune target in diffuse midline gliomas

Author information +
History +
PDF

Cite this article

Download citation ▾
Iker Ausejo-Mauleon,Sara Nuin,Marta M. Alonso. The rise of TIM-3: A promising immune target in diffuse midline gliomas. Clinical and Translational Medicine, 2024, 14(1): e1536 DOI:10.1002/ctm2.1536

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

132

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/